Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.166 EUR | +2.46% | +0.87% | -35.29% |
03-14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
03-11 | Abionyx: reduced net loss in 2023 | CF |
Quotes 5-day view
Delayed Quote Börse Stuttgart2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
---|---|---|---|---|
Last | 1.182 € | 1.142 € | 1.138 € | 1.166 € |
Change | +1.03% | -3.38% | -0.35% | +2.46% |
Performance
1 day | +2.46% | ||
Current month | +10.00% | ||
3 months | +12.12% | ||
6 months | +12.12% | ||
Current year | -35.29% | ||
1 year | +12.12% | ||
3 years | -16.12% | ||
5 years | +252.80% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.46% | +0.87% | -35.29% | +12.12% | 43.66M | ||
+2.77% | -0.35% | +11.91% | +40.72% | 118B | ||
+1.06% | -0.49% | +11.60% | +33.25% | 106B | ||
+1.87% | +3.76% | -4.68% | -4.26% | 24.28B | ||
+1.04% | +0.89% | -0.82% | -6.56% | 21.96B | ||
+0.31% | +0.55% | -10.12% | -28.92% | 18.16B | ||
+0.41% | -1.50% | -42.12% | -35.22% | 16.37B | ||
-3.50% | -2.53% | -17.47% | -32.63% | 15.56B | ||
-0.91% | -2.86% | +2.77% | +51.25% | 13.63B | ||
+4.28% | +5.12% | +34.58% | +5.00% | 12.27B | ||
-3.39% | +150.23% | +77.64% | +189.28% | 8.87B | ||
-1.71% | +3.60% | +7.26% | +55.34% | 7.75B | ||
+0.09% | +2.20% | +11.89% | +41.90% | 7.65B | ||
+0.25% | -1.43% | -3.92% | +24.97% | 7.42B | ||
-7.66% | -3.38% | -33.51% | -37.65% | 7.29B | ||
+0.78% | -0.78% | +234.55% | +183.52% | 6.87B | ||
Average | -0.12% | +10.25% | +15.27% | +30.76% | ||
Weighted average by Cap. | +1.05% | +3.42% | +10.18% | +27.61% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -41.18% | ||
2023 | -6.34% | ||
2022 | -17.78% | ||
2021 | +149.47% | ||
2020 | +213.19% | ||
2019 | -40.22% | ||
2018 | -72.95% | ||
2017 | -36.14% |
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- Quotes ABIONYX Pharma